107.10
-2.46%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About DSM-Firmenich
Its shares trade on Euronext Amsterdam under the ticker DSFIR.AS. It has been listed since 18 April 2023. In the fiscal year to 31 December 2025, it reported revenue of €9.03bn and a net loss of €1.08bn. At that date it held total assets of €29.34bn and shareholders' equity of €18.24bn.
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 18 Apr 2023
Leadership
Pay as last reported
- Mr. Thomas LeysenNon-Executive Independent Chairman of the Board, since 2023€780,055
- Mr. Dimitri De VreezeChief Executive Officer, Member of the Executive Committee, since 2023€7.5m
- Mr. Patrick FirmenichNon-Executive Vice Chairman of the Board, since 2023€288,216
- Mr. Ralf SchmeitzChief Financial Officer, Member of the Executive Committee
- Ms. Mieke Van De CapelleChief Human Resources Officer, Member of the Executive Committee, since 2023
- Ms. Jane SinclairChief Legal, Risk, Regulatory and Compliance Officer, Member of the Executive Committee, since 2023
- Mr. Emmanuel ButstraenMember of the Executive Committee, Chief Integration Officer, President of Perfumery & Beauty business, since 2023
- Mr. Philip EykermanBusiness Unit President Health, Nutrition & Care and Head of M&A, Member of the Executive Committee, since 2023
- Mr. Ivo LansbergenBusiness Unit President Animal Nutrition & Health, Member of the Executive Committee, since 2023
- Mr. Patrick NielsBusiness Unit President Taste, Texture & Health, Member of the Executive Committee, since 2023
- Ms. Sarah ReisingerChief Science & Research Officer, Member of the Executive Committee, since 2023
- Mr. Andre PomettaNon-Executive Director€231,629
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 76
- Environment
- 55
- Social
- 89
- Governance
- 83
- Direct emissions (scope 1)
- 594,400 t
- Energy emissions (scope 2)
- 476,900 t
- Value chain emissions (scope 3)
- 11,156,100 t
- Women in the workforce
- 31%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- DSM-Firmenich AG excels in global operations across nutrition, health, and beauty sectors.
- The company offers diverse product lines including natural flavors, CBD, and animal proteins.
- DSM-Firmenich AG's Health division provides customized vitamins and probiotics for consumers.
Weaknesses
- The company's reliance on natural ingredients may lead to supply chain vulnerabilities.
- DSM-Firmenich AG faces challenges in scaling CBD product lines due to regulatory constraints.
- Animal Nutrition & Health division depends heavily on agricultural commodity prices.
Opportunities
- Expanding into emerging markets like India and Brazil for nutritional products.
- Growing demand for plant-based ingredients in the Taste, Texture & Health segment.
- Increasing global focus on health and wellness drives market growth for DSM-Firmenich AG.
Threats
- Rising raw material costs impact profitability in the Chemicals sector.
- Regulatory changes in the EU could affect CBD product sales.
- Competition from established players in the Animal Nutrition & Health market.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.